Podcast with MedAsian

Rex

China healthcare policy landscape

Episodes

  1. MAR 17

    2026 "Two Sessions" policy outlook and government affairs actions in a dynamic business environment

    The quick summary of this episode of Podcast with MedAsian. New 5-Year Plan & Shift to Quality: 2026 marks the start of China’s 15th Five-Year Plan, with a moderate 4.5–5% GDP target that prioritizes quality over speed. The focus is on structural upgrading and higher standards, not short-term stimulus.Prioritized Sectors: Policy is heavily concentrated on industries that enhance long-term resilience, including advanced manufacturing (AI, 6G, NEV), healthcare innovation, and green technology, with a strong emphasis on technological self-reliance.Higher Expectations for Business: The environment is becoming more demanding. Companies face growing expectations around localization, supply chain integration, and alignment with national policy goals to succeed.Proactive Government Affairs is Key: Businesses must move beyond monitoring to early-stage policy shaping. Engaging with ministries and regulators before rules are finalized allows companies to contribute expertise and influence practical implementation.Leverage Regional Pilots: Significant policy breakthroughs can happen at the regional level. Companies should utilize pilot zones (e.g., Boao for healthcare) to test innovations and demonstrate value, which can later inform national policy.

    30 min

  2. MAR 9

    Human-led vs. AI-led communications: APAC in action

    The Core Conflict: In APAC, culture remains the superpower. AI can process data, but it cannot read a room, navigate hierarchy, or sense unspoken political tension. Key Takeaway: "AI informs speed. Human judgment protects authority and sensibility." Why It Matters: Global playbooks fail when they ignore local context In healthcare, "how/why" matters as much as "what"—AI misses ethical nuance The winning formula: Human instinct as compass, AI as engine Future Communicators: Must evolve from storytellers to trusted advisors—frontline strategists who translate cultural shifts into actionable leadership insights. Bottom line: In APAC, contextual intelligence = competitive advantage. 🤝

    25 min

  3. FEB 24

    Paving the Pathway to Healthcare Innovation (Part 2)

    In our last podcast, we touched on topics around: 1. policy breakthroughs and current regulatory barriers in pilot zones across China, 2. applying real-world data to streamline the review of imported medical products, 3. the lingering challenges for patients to access innovative healthcare products that have already launched overseas 4. some suggestions for future policy breakthroughs.       In this podcast, we cover why imported innovative medical devices account for only 15% of green channel approvals in China—and what needs to change. We also break down: ✅ Why 60% of top hospitals delay adoption by 6–12 months ✅ How NRDL timelines shrank from 5 years to 1, yet access remains limited ✅ The policy fixes needed—from RWE mandates to national innovation definitions Tune in for the full discussion.

    21 min

  4. FEB 2

    Pathway to Healthcare Innovation (Part 1)

    In this podcast, we will mostly dive into some of the latest but also long-standing industry and regulatory issues in China surrounding the accessibility of innovative healthcare products, their current policy regulation standings, and what are areas where the industry can call for additional improvement actions.   These actions will not only benefit multinational and domestic healthcare businesses, but also will improve China’s overall healthcare landscape and development quality.

    13 min
  • 4 Episodes

About

China healthcare policy landscape

Information

  • Creator
    Rex
  • Years Active
    2K
  • Episodes
    4
  • Rating
    Clean
  • Copyright
    © 2026 Podcast with MedAsian
  • Show Website
    Podcast with MedAsian